Skip to content
2000
Volume 20, Issue 8
  • ISSN: 1574-8855
  • E-ISSN: 2212-3903

Abstract

Kidney stone disease, or nephrolithiasis, is a common condition with high morbidity that affects people all over the world. It is important to comprehend the etiology and contemporary developments in its management to enhance patient results. In this study, we describe a thorough analysis of nephrolithiasis, with particular attention to its etiology, current developments in treatment modalities, and ongoing clinical studies by utilizing electronic databases. A thorough search of the literature was carried out to find pertinent papers published through 2024 and the genesis of nephrolithiasis, new treatment developments, and ongoing clinical trials. The review clarifies the complex interplay between dietary variables, metabolic disorders, and genetic susceptibility that leads to nephrolithiasis. The most recent developments in treatment modalities, such as minimally invasive operations and medication therapies, are examined. Furthermore, ongoing clinical trials examining new treatments and preventative measures are emphasized. A multidisciplinary approach is necessary for the optimal care of nephrolithiasis because it is a complex condition influenced by a variety of factors. While ongoing clinical trials hold promise for additional innovation in nephrolithiasis therapy and prevention, recent therapeutic developments offer promising pathways for enhanced patient care. Addressing the difficulties brought on by this common ailment requires cooperation and ongoing study.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdth/10.2174/0115748855317406240823101746
2024-09-16
2025-12-19

  • From This Site

    /content/journals/cdth/10.2174/0115748855317406240823101746
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. TiseliusH.G. Urinary tract stone disease: Are all problems solved?Scand. J. Urol.20134714910.3109/00365599.2012.68048922545984
     [Google Scholar]
  2. DevuystO. PirsonY. Genetics of hypercalciuric stone forming diseases.Kidney Int.20077291065107210.1038/sj.ki.500244117687260
     [Google Scholar]
  3. WangZ. ZhangY. ZhangJ. Recent advances on the mechanisms of kidney stone formation.Int. J. Mol. Med.2021482110
     [Google Scholar]
  4. SinghP.P. JhaS. ChandraR. Herabal remedies for kidney stone.Pharm. Times20063893436
     [Google Scholar]
  5. SkolarikosA. StraubM. KnollT. SaricaK. SeitzC. PetříkA. TürkC. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.Eur. Urol.201567475076310.1016/j.eururo.2014.10.02925454613
     [Google Scholar]
  6. LotanY. Buendia JiménezI. Lenoir-WijnkoopI. DaudonM. MolinierL. TackI. NuijtenM.J.C. Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness.J. Urol.2013189393593910.1016/j.juro.2012.08.25423017509
     [Google Scholar]
  7. TaylorE.N. StampferM.J. CurhanG.C. Obesity, weight gain, and the risk of kidney stones.JAMA2005293445546210.1001/jama.293.4.45515671430
     [Google Scholar]
  8. SteelyA. WorcesterE. ProchaskaM. Contrasting Response of Urine Stone Risk to Medical Treatment in Calcium Oxalate Versus Calcium Phosphate Stone Formers.Kidney36020245222823610.34067/KID.000000000000036238251931
     [Google Scholar]
  9. TandonC. ChaudharyA. SinglaS.K. In vitro evaluation of Terminalia arjuna on calcium phosphate and calcium oxalate crystallization.Indian J. Pharm. Sci.201072334034510.4103/0250‑474X.7048021188043
     [Google Scholar]
  10. KaragiannisA. SkolarikosA. AlexandrescuE. BasicD. GeavleteP. MalettaA. MuslumanogluA.Y. PapatsorisA. PetkovaK. SaidiS. SkakicA. SaltirovI. SaricaK. StavridisS. YilmazO. TrinchieriA. Epidemiologic study of urolithiasis in seven countries of South-Eastern Europe: S.E.G.U.R. 1 study.Arch. Ital. Urol. Androl.201789317317710.4081/aiua.2017.3.17328969396
     [Google Scholar]
  11. BensatalA. OuahraniM.R. Inhibition of crystallization of calcium oxalate by the extraction of Tamarix gallica L.Urol. Res.200836628328710.1007/s00240‑008‑0157‑119002446
     [Google Scholar]
  12. KumarS.B.N. KumarK.G. SrinivasaV. BilalS. A review on urolithiasis.Int. J. Univers. Pharm. Life Sci.201222269280
     [Google Scholar]
  13. AhmedK. DasguptaP. KhanM.S. Cystine calculi: challenging group of stones.Postgrad. Med. J.20068297479980110.1136/pgmj.2005.04415617148700
     [Google Scholar]
  14. ChhiberN. SharmaM. KaurT. SinglaS. Mineralization in health and mechanism of kidney stone formation.Int. J. Pharm. Sci. Invent.2014312531
     [Google Scholar]
  15. TalatiV.M. SoaresR.M.O. KhambatiA. NadlerR.B. PerryK.T.Jr Trends in urinary calculi composition from 2005 to 2015: a single tertiary center study.Urolithiasis202048430531110.1007/s00240‑019‑01151‑z31372690
     [Google Scholar]
  16. DursunM. OtunctemurA. OzbekE. Kidney stones and ceftriaxone.Urology2015
     [Google Scholar]
  17. NgoT.C. AssimosD.G. Uric Acid nephrolithiasis: recent progress and future directions.Rev. Urol.200791172717396168
     [Google Scholar]
  18. AggarwalKP NarulaS KakkarM TandonC Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.Biomed Res Int201310.1155/2013/292953
     [Google Scholar]
  19. FlanniganR. ChoyW.H. ChewB. LangeD. Renal struvite stones—pathogenesis, microbiology, and management strategies.Nat. Rev. Urol.201411633334110.1038/nrurol.2014.9924818849
     [Google Scholar]
  20. Dominguez-GutierrezP.R. KwendaE.P. KhanS.R. CanalesB.K. Immunotherapy for stone disease.Curr. Opin. Urol.202030218318910.1097/MOU.000000000000072931913203
     [Google Scholar]
  21. RatkalkarV.N. KleinmanJ.G. Mechanisms of stone formation.Clin. Rev. Bone Miner. Metab.201193-418719710.1007/s12018‑011‑9104‑822229020
     [Google Scholar]
  22. Espinosa-OrtizE.J. EisnerB.H. LangeD. GerlachR. Current insights into the mechanisms and management of infection stones.Nat. Rev. Urol.2019161355310.1038/s41585‑018‑0120‑z30470787
     [Google Scholar]
  23. PeerapenP. ThongboonkerdV. Kidney stone proteomics: an update and perspectives.Expert Rev. Proteomics202118755756910.1080/14789450.2021.196230134320328
     [Google Scholar]
  24. KhanS.R. CanalesB.K. Dominguez-GutierrezP.R. Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation.Nat. Rev. Nephrol.202117641743310.1038/s41581‑020‑00392‑133514941
     [Google Scholar]
  25. BorghiL. MeschiT. AmatoF. BrigantiA. NovariniA. GianniniA. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.J. Urol.1996155383984310.1016/S0022‑5347(01)66321‑38583588
     [Google Scholar]
  26. CorneliusJ.G. PeckA.B. Colonization of the neonatal rat intestinal tract from environmental exposure to the anaerobic bacterium Oxalobacter formigenes.J. Med. Microbiol.200453324925410.1099/jmm.0.05418‑014970252
     [Google Scholar]
  27. BernardJ. SongL. HendersonB. TasianG.E. Association between daily water intake and 24-hour urine volume among adolescents with kidney stones.Urology202014015015410.1016/j.urology.2020.01.02432004558
     [Google Scholar]
  28. YamaguchiS. WiessnerJ.H. HasegawaA.T. HungL. MandelG.S. MandelN.S. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.Int. J. Urol.200512329029810.1111/j.1442‑2042.2005.01038.x15828958
     [Google Scholar]
  29. HiroseM. YasuiT. OkadaA. HamamotoS. ShimizuH. ItohY. TozawaK. KohriK. Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney.Int. J. Urol.2010171839210.1111/j.1442‑2042.2009.02410.x19919640
     [Google Scholar]
  30. XiQ. OuyangJ. PuJ. HouJ. WangS. High concentration of calcium stimulates calcium oxalate crystal attachment to rat tubular epithelial NRK cells through osteopontin.Urology2015864844.e1844.e510.1016/j.urology.2015.07.01826216642
     [Google Scholar]
  31. CurhanG.C. WillettW.C. SpeizerF.E. SpiegelmanD. StampferM.J. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women.Ann. Intern. Med.1997126749750410.7326/0003‑4819‑126‑7‑199704010‑000019092314
     [Google Scholar]
  32. ŠálekT. Extreme diet without calcium may lead to hyperoxaluria and kidney stone recurrence—A case study.J. Clin. Lab. Anal.20203412e2351210.1002/jcla.2351232761639
     [Google Scholar]
  33. TrinchieriA. MalettaA. LizzanoR. MarchesottiF. Potential renal acid load and the risk of renal stone formation in a case–control study.Eur. J. Clin. Nutr.201367101077108010.1038/ejcn.2013.15524002043
     [Google Scholar]
  34. RashedT. MenonM. ThamilselvanS. Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants.Am. J. Nephrol.200424555756810.1159/00008204315539792
     [Google Scholar]
  35. ChaturvediL.S. KoulS. SekhonA. BhandariA. MenonM. KoulH.K. Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells.J. Biol. Chem.200227715133211333010.1074/jbc.M10820320011823457
     [Google Scholar]
  36. Palomeque MatosM. Urinary lithiasis and extracorporeal shock wave lithotripsy: new approachments.2023
     [Google Scholar]
  37. BayomyO. ZaheerS. WilliamsJ.S. CurhanG. VaidyaA. Disentangling the relationships between the renin–angiotensin–aldosterone system, calcium physiology, and risk for kidney stones.J. Clin. Endocrinol. Metab.202010561937194610.1210/clinem/dgaa12332163150
     [Google Scholar]
  38. NakazawaY. InoueS. NakamuraY. IidaY. IshigakiY. MiyazawaK. High‐salt diet promotes crystal deposition through hypertension in Dahl salt‐sensitive rat model.Int. J. Urol.201926883984610.1111/iju.1403531257672
     [Google Scholar]
  39. HongY. ZhangZ. YeH. AnL. HuangX. XuQ. Effects of high-sodium diet on lithogenesis in a rat experimental model of calcium oxalate stones.Transl. Androl. Urol.202110263664210.21037/tau‑20‑122633718066
     [Google Scholar]
  40. KriegerN.S. GrynpasM. VandenEyndeA. AsplinJ.R. FrickK.K. KimM.H. RamosF.M. GranjaI. BushinskyD.A. Low sodium diet decreases stone formation in genetic hypercalciuric stone-forming rats.Nephron J.2019142214715810.1159/00049711730726853
     [Google Scholar]
  41. SeegerH. KaelinA. FerraroP.M. WeberD. JaegerP. AmbuehlP. RobertsonW.G. UnwinR. WagnerC.A. MohebbiN. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.BMC Nephrol.201718134910.1186/s12882‑017‑0755‑729202723
     [Google Scholar]
  42. ErmerT. NazzalL. TioM.C. WaikarS. AronsonP.S. KnaufF. Oxalate homeostasis.Nat. Rev. Nephrol.202319212313810.1038/s41581‑022‑00643‑336329260
     [Google Scholar]
  43. HuangY. ZhangY.H. ChiZ.P. HuangR. HuangH. LiuG. ZhangY. YangH. LinJ. YangT. CaoS.Z. The handling of oxalate in the body and the origin of oxalate in calcium oxalate stones.Urol. Int.20201043-416717610.1159/00050441731805567
     [Google Scholar]
  44. LeeY.H. HuangW.C. TsaiJ.Y. LuC.M. ChenW.C. LeeM.H. HsuH.S. HuangJ.K. ChangL.S. Epidemiological studies on the prevalence of upper urinary calculi in Taiwan.Urol. Int.200268317217710.1159/00004844511919463
     [Google Scholar]
  45. ReckerP. BeckB.B. SikoraP. GöbelH. KemperM.J. NazcoA. Martin-HiguerasC. HoppeB. Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I.Sci. Rep.20221211672510.1038/s41598‑022‑19584‑936202824
     [Google Scholar]
  46. KimS. KimS.J. ChuS.T. YangS.H. KimY.S. ChaR. A rare case of hyperoxaluria presenting with acute liver injury and stone-free kidney injury.Kidney Res. Clin. Pract.201534211311610.1016/j.krcp.2014.09.00626484032
     [Google Scholar]
  47. CrivelliJ.J. MitchellT. KnightJ. WoodK.D. AssimosD.G. HolmesR.P. FargueS. Contribution of dietary oxalate and oxalate precursors to urinary oxalate excretion.Nutrients20201316210.3390/nu1301006233379176
     [Google Scholar]
  48. LjunghallS. DanielsonB.G. A prospective study of renal stone recurrences.Br. J. Urol.198456212212410.1111/j.1464‑410X.1984.tb05346.x6498430
     [Google Scholar]
  49. TrinchieriA. OstiniF. NespoliR. RoveraF. MontanariE. ZanettiG. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone.J. Urol.19991621273010.1097/00005392‑199907000‑0000710379732
     [Google Scholar]
  50. FriedR. CarltonR. Flaxseed: Evidence-based Cardiovascular and other Medicinal Benefits.CRC Press202210.1201/b22986
     [Google Scholar]
  51. SudharsonS. KokilP. Computer-aided diagnosis system for the classification of multi-class kidney abnormalities in the noisy ultrasound images.Comput. Methods Programs Biomed.202120510607110.1016/j.cmpb.2021.10607133887632
     [Google Scholar]
  52. CunninghamP. NobleH. Al-ModheferA.K. WalshI. Kidney stones: pathophysiology, diagnosis and management.Br. J. Nurs.201625201112111610.12968/bjon.2016.25.20.111227834524
     [Google Scholar]
  53. KhanS.R. ShevockP.N. HackettR.L. Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis.J. Urol.1992147122623010.1016/S0022‑5347(17)37202‑61729537
     [Google Scholar]
  54. StraubM. HautmannR.E. Developments in stone prevention.Curr. Opin. Urol.200515211912610.1097/01.mou.0000160627.36236.6b15725936
     [Google Scholar]
  55. MikamiK. AkakuraK. TakeiK. UedaT. MizoguchiK.I. NodaM. MiyakeM. ItoH. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation.Int. J. Urol.200310629329610.1046/j.1442‑2042.2003.00634.x12757596
     [Google Scholar]
  56. TurneyB.W. ApplebyP.N. ReynardJ.M. NobleJ.G. KeyT.J. AllenN.E. Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC).Eur. J. Epidemiol.201429536336910.1007/s10654‑014‑9904‑524752465
     [Google Scholar]
  57. NooriN. HonarkarE. GoldfarbD.S. Kalantar-ZadehK. TaheriM. ShakhssalimN. ParvinM. BasiriA. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.Am. J. Kidney Dis.201463345646310.1053/j.ajkd.2013.11.02224560157
     [Google Scholar]
  58. FerraroP.M. TaylorE.N. GambaroG. CurhanG.C. Dietary and lifestyle risk factors associated with incident kidney stones in men and women.J. Urol.2017198485886310.1016/j.juro.2017.03.12428365271
     [Google Scholar]
  59. MaddahiN. AghamirS.M.K. ModdaresiS.S. MirzaeiK. AlizadehS. YekaninejadM.S. The association of Dietary Approaches to Stop Hypertension-style diet with urinary risk factors of kidney stones formation in men with nephrolithiasis.Clin. Nutr. ESPEN20203917317910.1016/j.clnesp.2020.06.02132859313
     [Google Scholar]
  60. RodriguesF.G. LimaT.M. ZambranoL. HeilbergI.P. Análise do padrão alimentar de pacientes litiásicos: similaridades com o padrão de dieta DASH.Brazilian J Nephrol.20204233834810.1590/2175‑8239‑jbn‑2019‑0183
     [Google Scholar]
  61. PowersC.J. TinterowM.M. BurpeeJ.F. Extracorporeal shock wave lithotripsy: a study of renal stone differences.Kans. Med.198990119222709649
     [Google Scholar]
  62. Abu-GhanemY. KleinmannN. ErlichT. WinklerH.Z. ZilbermanD.E. The Impact of Dietary Modifications and Medical Management on 24-Hour Urinary Metabolic Profiles and the Status of Renal Stone Disease in Recurrent Stone Formers.Isr. Med. Assoc. J.2021231121633443336
     [Google Scholar]
  63. AugeB.K. PremingerG.M. Surgical management of urolithiasis.Endocrinol. Metab. Clin. North Am.20023141065108210.1016/S0889‑8529(02)00033‑612474646
     [Google Scholar]
  64. SoferM. WattersonJ.D. WollinT.A. NottL. RazviH. DenstedtJ.D. Holmium:YAG laser lithotripsy for upper urinary tract calculi in 598 patients.J. Urol.20021671313410.1016/S0022‑5347(05)65376‑111743269
     [Google Scholar]
  65. DelvecchioF.C. PremingerG.M. Medical management of stone disease.Curr. Opin. Urol.200313322923310.1097/00042307‑200305000‑0001112692447
     [Google Scholar]
  66. LamJ.S. GreeneT.D. GuptaM. Treatment of proximal ureteral calculi: holmium:YAG laser ureterolithotripsy versus extracorporeal shock wave lithotripsy.J. Urol.200216751972197610.1016/S0022‑5347(05)65065‑311956420
     [Google Scholar]
  67. ChaiyaritS. ThongboonkerdV. Defining and systematic analyses of aggregation indices to evaluate degree of calcium oxalate crystal aggregation.Front Chem.2017511310.3389/fchem.2017.0011329270403
     [Google Scholar]
  68. Fong-ngernK. PeerapenP. SinchaikulS. ChenS.T. ThongboonkerdV. Large-scale identification of calcium oxalate monohydrate crystal-binding proteins on apical membrane of distal renal tubular epithelial cells.J. Proteome Res.201110104463447710.1021/pr200687821859077
     [Google Scholar]
  69. KhanS.R. PearleM.S. RobertsonW.G. GambaroG. CanalesB.K. DoiziS. TraxerO. TiseliusH.G. Kidney stones.Nat. Rev. Dis. Primers2016211600810.1038/nrdp.2016.827188687
     [Google Scholar]
  70. KhanS.R. Histological aspects of the “fixed-particle” model of stone formation: animal studies.Urolithiasis2017451758710.1007/s00240‑016‑0949‑727896391
     [Google Scholar]
  71. RandallA. The origin and growth of renal calculi.Ann. Surg.193710561009102710.1097/00000658‑193706000‑0001417856988
     [Google Scholar]
  72. EvanA.P. CoeF.L. LingemanJ. BledsoeS. WorcesterE.M. Randall’s plaque in stone formers originates in ascending thin limbs.Am. J. Physiol. Renal Physiol.20183155F1236F124210.1152/ajprenal.00035.201830066583
     [Google Scholar]
  73. SasmazM.İ. KirpatV. The relationship between the severity of pain and stone size, hydronephrosis and laboratory parameters in renal colic attack.Am. J. Emerg. Med.201937112107211010.1016/j.ajem.2019.06.01331196585
     [Google Scholar]
  74. LærumE. LarsenS. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice.Acta Med. Scand.1984215438338910.1111/j.0954‑6820.1984.tb05023.x6375276
     [Google Scholar]
  75. BrisbaneW. BaileyM.R. SorensenM.D. An overview of kidney stone imaging techniques.Nat. Rev. Urol.2016131165466210.1038/nrurol.2016.15427578040
     [Google Scholar]
  76. QuhalF. SeitzC. Guideline of the guidelines: urolithiasis.Curr. Opin. Urol.202131212512910.1097/MOU.000000000000085533399368
     [Google Scholar]
  77. HuenS.C. GoldfarbD.S. Adverse metabolic side effects of thiazides: implications for patients with calcium nephrolithiasis.J. Urol.200717741238124310.1016/j.juro.2006.11.04017382697
     [Google Scholar]
  78. De PerrotT. HofmeisterJ. BurgermeisterS. MartinS.P. FeutryG. KleinJ. MontetX. Differentiating kidney stones from phleboliths in unenhanced low-dose computed tomography using radiomics and machine learning.Eur. Radiol.20192994776478210.1007/s00330‑019‑6004‑730747299
     [Google Scholar]
  79. LiD. XiaoC. LiuY. ChenZ. HassanH. SuL. LiuJ. LiH. XieW. ZhongW. HuangB. Deep segmentation networks for segmenting kidneys and detecting kidney stones in unenhanced abdominal CT images.Diagnostics (Basel)2022128178810.3390/diagnostics1208178835892498
     [Google Scholar]
  80. IslamM.N. HasanM. HossainM.K. AlamM.G.R. UddinM.Z. SoyluA. Vision transformer and explainable transfer learning models for auto detection of kidney cyst, stone and tumor from CT-radiography.Sci. Rep.20221211144010.1038/s41598‑022‑15634‑435794172
     [Google Scholar]
  81. CaglayanA. HorsanaliM.O. KocadurduK. IsmailogluE. GuneyliS. Deep learning model-assisted detection of kidney stones on computed tomography.Int. Braz J Urol202248583083910.1590/s1677‑5538.ibju.2022.013235838509
     [Google Scholar]
  82. MoranM.E. Uric acid stone disease.Front. Biosci.200386117810.2741/117812957851
     [Google Scholar]
  83. HeilbergI.P. GoldfarbD.S. Optimum nutrition for kidney stone disease.Adv. Chronic Kidney Dis.201320216517410.1053/j.ackd.2012.12.00123439376
     [Google Scholar]
  84. HealyK.A. OganK. Nonsurgical management of urolithiasis: an overview of expulsive therapy.J. Endourol.200519775976710.1089/end.2005.19.75916190824
     [Google Scholar]
  85. LängkvistM. JendebergJ. ThunbergP. LoutfiA. LidénM. Computer aided detection of ureteral stones in thin slice computed tomography volumes using Convolutional Neural Networks.Comput. Biol. Med.20189715316010.1016/j.compbiomed.2018.04.02129730498
     [Google Scholar]
  86. SafarinejadM.R. Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors.Urol. Res.2007352738210.1007/s00240‑007‑0084‑617361397
     [Google Scholar]
  87. ScalesC.D. SmithA.C. HanleyJ.M. SaigalC.S. Urologic diseases in America project. Preval kidney stones United States.Eur. Urol.20126216016510.1016/j.eururo.2012.03.05222498635
     [Google Scholar]
  88. PakC.Y.C. BrittonF. PetersonR. WardD. NorthcuttC. BreslauN.A. McGuireJ. SakhaeeK. BushS. NicarM. NormanD.A. PetersP. Ambulatory evaluation of nephrolithiasis.Am. J. Med.1980691193010.1016/0002‑9343(80)90495‑76247914
     [Google Scholar]
  89. Chung-JenS. ShevockP.N. KhanS.R. HackettR.L. Effect of magnesium on calcium oxalate urolithiasis.J. Urol.199114551092109510.1016/S0022‑5347(17)38541‑52016799
     [Google Scholar]
  90. EttingerB. CitronJ.T. LivermoreB. DolmanL.I. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.J. Urol.1988139467968410.1016/S0022‑5347(17)42599‑73280829
     [Google Scholar]
  91. PakC.Y.C. SakhaeeK. FullerC. Successful management of uric acid nephrolithiasis with potassium citrate.Kidney Int.198630342242810.1038/ki.1986.2013784284
     [Google Scholar]
  92. CoeF.L. ClarkC. ParksJ.H. AsplinJ.R. Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugs.J. Urol.2001166268869310.1016/S0022‑5347(05)66044‑211458118
     [Google Scholar]
  93. MortensenJ.T. SchultzA. ØstergaardA.H. Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones.Int. Urol. Nephrol.198618326526910.1007/BF020827123533825
     [Google Scholar]
  94. DolinD.J. AsplinJ.R. FlagelL. GrassoM. GoldfarbD.S. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria.J. Endourol.200519342943210.1089/end.2005.19.42915865542
     [Google Scholar]
  95. GriffithD.P. KhonsariF. SkurnickJ.H. JamesK.E. GroupV.A.C.S. A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients.J. Urol.1988140231832410.1016/S0022‑5347(17)41592‑83294442
     [Google Scholar]
  96. BorghiL. MeschiT. SchianchiT. BrigantiA. GuerraA. AllegriF. NovariniA. Urine volume: stone risk factor and preventive measure.Nephron J.199981Suppl. 1313710.1159/0000462969873212
     [Google Scholar]
  97. EscribanoJ BalaguerA PagoneF FeliuA Pharmacological interventions for preventing complications in idiopathic hypercalciuria.Cochrane Database Syst Rev20091
     [Google Scholar]
  98. MoeO.W. PearleM.S. SakhaeeK. Pharmacotherapy of urolithiasis: evidence from clinical trials.Kidney Int.201179438539210.1038/ki.2010.38920927039
     [Google Scholar]
  99. HessB. JostC. ZipperleL. TakkinenR. JaegerP. High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans.Nephrol. Dial. Transplant.19981392241224710.1093/ndt/13.9.22419761503
     [Google Scholar]
  100. ZehnderP. RothB. BirkhäuserF. SchneiderS. SchmutzR. ThalmannG.N. StuderU.E. A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter.Eur. Urol.201159463764410.1016/j.eururo.2011.01.02621296481
     [Google Scholar]
  101. GranzB. KöhlerG. What makes a shock wave efficient in lithotripsy?J. Stone Dis.19924212312810149177
     [Google Scholar]
  102. EisenmengerW. The mechanisms of stone fragmentation in ESWL.Ultrasound Med. Biol.200127568369310.1016/S0301‑5629(01)00345‑311397533
     [Google Scholar]
  103. BergsdorfT.H. ThüroffS. ChaussyC.H. The isolated perfused kidney: an in vitro test system for evaluation of renal tissue damage induced by high-energy shockwaves sources.J. Endourol.200519788388810.1089/end.2005.19.88316190851
     [Google Scholar]
  104. NeisiusA. SmithN.B. SankinG. KuntzN.J. MaddenJ.F. FovargueD.E. MitranS. LipkinM.E. SimmonsW.N. PremingerG.M. ZhongP. Improving the lens design and performance of a contemporary electromagnetic shock wave lithotripter.Proc. Natl. Acad. Sci. USA201411113E1167E117510.1073/pnas.131920311124639497
     [Google Scholar]
  105. SokolovD.L. BaileyM.R. CrumL.A. Use of a dual-pulse lithotripter to generate a localized and intensified cavitation field.J. Acoust. Soc. Am.200111031685169510.1121/1.139422111572377
     [Google Scholar]
  106. SheirK.Z. El-DiastyT.A. IsmailA.M. Evaluation of a synchronous twin‐pulse technique for shock wave lithotripsy: the first prospective clinical study.BJU Int.200595338939310.1111/j.1464‑410X.2005.05306.x15679800
     [Google Scholar]
  107. ZhouY. CocksF.H. PremingerG.M. ZhongP. Innovations in shock wave lithotripsy technology: updates in experimental studies.J. Urol.200417251892189810.1097/01.ju.0000142827.41910.a215540748
     [Google Scholar]
  108. DuryeaA.P. HallT.L. MaxwellA.D. XuZ. CainC.A. RobertsW.W. Histotripsy erosion of model urinary calculi.J. Endourol.201125234134410.1089/end.2010.040721091223
     [Google Scholar]
  109. MalhotraK.K. Medical aspects of renal stones.J Indian Acad Clin Med.200894282
     [Google Scholar]
  110. SchepersM.S.J. van der BoomB.G. RomijnJ.C. SchröoderandF.H. VerkoelenC.F. Urinary crystallization inhibitors do not prevent crystal binding.J. Urol.200216741844184710.1016/S0022‑5347(05)65246‑911912445
     [Google Scholar]
  111. PeerapenP. ThongboonkerdV. p38 MAPK mediates calcium oxalate crystal-induced tight junction disruption in distal renal tubular epithelial cells.Sci. Rep.201331104110.1038/srep0104123304432
     [Google Scholar]
  112. KoulS. KhandrikaL. PshakT.J. IguchiN. PalM. SteffanJ.J. KoulH.K. Oxalate upregulates expression of IL-2Rβ and activates IL-2R signaling in HK-2 cells, a line of human renal epithelial cells.Am. J. Physiol. Renal Physiol.20143069F1039F104610.1152/ajprenal.00462.201324523387
     [Google Scholar]
  113. HsiehN. ShihC.H. ChenH.Y. WuM.C. ChenW.C. LiC.W. Effects of Tamm-Horsfall protein on the protection of MCDK cells from oxalate induced free radical injury.Urol. Res.2003311101610.1007/s00240‑003‑0298‑112624657
     [Google Scholar]
  114. EvanA.P. LingemanJ.E. CoeF.L. ParksJ.H. BledsoeS.B. ShaoY. SommerA.J. PatersonR.F. KuoR.L. GrynpasM. Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle.J. Clin. Invest.2003111560761610.1172/JCI1703812618515
     [Google Scholar]
  115. DawsonC.H. TomsonC.R.V. Kidney stone disease: pathophysiology, investigation and medical treatment.Clin. Med201212546747110.7861/clinmedicine.12‑5‑46723101150
     [Google Scholar]
  116. YuenJ.W.M. GohelM.D.I. PoonN. ShumD.K.Y. TamP. AuD.W.T. The initial and subsequent inflammatory events during calcium oxalate lithiasis.Clin. Chim. Acta201041115-161018102610.1016/j.cca.2010.03.01520347754
     [Google Scholar]
/content/journals/cdth/10.2174/0115748855317406240823101746
Loading
A Comprehensive Review on Nephrolithiasis: Etiology Recent Advances and Clinical Trials
Curr Drug Ther 20, 1179 (2025); https://doi.org/10.2174/0115748855317406240823101746
/content/journals/cdth/10.2174/0115748855317406240823101746
/content/journals/cdth/10.2174/0115748855317406240823101746
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Kidney stone; management; mechanism; nephrolithiasis; pharmacological treatment; recent advancements

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test